Table 3.
Outcome: visual quality of life at 1 year | ||||
Predictors entered into initial model: baseline VFQ-25, age, gender, education, AMD grade, cataract grade, unilateral/sequential surgery, GDS at 1 year, ACE-R | ||||
Initial model: | n=91, R2=0.44, ANOVA for model: F=6.7, p<0.001 β for ACE-R=0.20, p=0.03 |
|||
Final model: | n=91, R2=0.41, ANOVA for model: F=19.1, p<0.001 | |||
B | SE(B) | β | p Value | |
Constant | 66.59 | 8.42 | <0.001 | |
Baseline VFQ-25 | 0.15 | 0.06 | 0.25 | 0.009 |
GDS | −1.18 | 0.30 | −0.39 | <0.001 |
ACE-R | 0.19 | 0.08 | 0.22 | 0.014† |
Outcome: visual acuity at 1 year | ||||
Predictors entered into initial model: baseline VA, age, gender, education, AMD grade, cataract grade, unilateral/sequential surgery, GDS at 1 year, ACE-R | ||||
Initial model: | n=91, R2=0.30, ANOVA for model: F=3.9, p=0.001 β for ACE-R=−0.30, p=0.005 |
|||
Final model: | n=91, R2=0.28, ANOVA for model: F=11.2, p<0.001* | |||
B | SE(B) | β | p Value | |
Constant | 0.37 | 0.10 | <0.001 | |
Baseline VA | 0.30 | 0.08 | 0.32 | 0.001 |
Unilateral/sequential surgery | −0.05 | 0.02 | −0.22 | 0.02 |
ACE-R | −0.003 | 0.001 | −0.32 | 0.001 |
*When the two cases with standardised residuals >3 were removed, ACE-R had a p value of 0.5 in the initial model and was removed by the stepwise regression before the final model.
ACE-R, Revised Addenbrooke's Cognitive Examination; AMD, age related macular degeneration; GDS, Geriatric Depression Scale; VA, visual acuity; VFQ-25, 25 item Visual Functioning Questionnaire; ANOVA, analysis of variance.